Raymond James & Associates Sells 3,278 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS)

Raymond James & Associates decreased its position in Integral Ad Science Holding Corp. (NASDAQ:IASFree Report) by 7.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,535 shares of the company’s stock after selling 3,278 shares during the quarter. Raymond James & Associates’ holdings in Integral Ad Science were worth $583,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Integral Ad Science by 15.2% during the third quarter. Vanguard Group Inc. now owns 7,325,778 shares of the company’s stock valued at $87,104,000 after buying an additional 966,280 shares during the period. Clearbridge Investments LLC lifted its holdings in shares of Integral Ad Science by 6.2% in the third quarter. Clearbridge Investments LLC now owns 3,279,915 shares of the company’s stock worth $38,998,000 after buying an additional 191,075 shares in the last quarter. TimesSquare Capital Management LLC lifted its holdings in shares of Integral Ad Science by 32.2% in the third quarter. TimesSquare Capital Management LLC now owns 2,486,748 shares of the company’s stock worth $29,567,000 after buying an additional 605,824 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Integral Ad Science by 88.4% in the third quarter. Jacobs Levy Equity Management Inc. now owns 1,167,392 shares of the company’s stock worth $13,880,000 after buying an additional 547,856 shares in the last quarter. Finally, Qube Research & Technologies Ltd purchased a new stake in shares of Integral Ad Science in the third quarter worth about $5,548,000. Institutional investors own 95.78% of the company’s stock.

Integral Ad Science Stock Down 0.9 %

Shares of Integral Ad Science stock opened at $9.47 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.21 and a current ratio of 3.21. Integral Ad Science Holding Corp. has a 52-week low of $8.92 and a 52-week high of $20.88. The stock has a market capitalization of $1.51 billion, a price-to-earnings ratio of 236.81, a P/E/G ratio of 1.66 and a beta of 1.60. The company’s 50 day moving average price is $10.76 and its 200-day moving average price is $12.95.

Integral Ad Science (NASDAQ:IASGet Free Report) last issued its earnings results on Tuesday, February 27th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.03. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The firm had revenue of $134.30 million for the quarter, compared to analysts’ expectations of $131.27 million. During the same quarter last year, the business earned $0.07 earnings per share. The business’s revenue was up 14.4% on a year-over-year basis. Equities research analysts forecast that Integral Ad Science Holding Corp. will post 0.16 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. BMO Capital Markets lowered their target price on shares of Integral Ad Science from $18.00 to $16.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 28th. Bank of America assumed coverage on shares of Integral Ad Science in a research note on Thursday, January 11th. They issued a “buy” rating and a $19.00 target price on the stock. Raymond James downgraded shares of Integral Ad Science from a “strong-buy” rating to an “outperform” rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Wednesday, February 28th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $12.00 target price (down from $18.00) on shares of Integral Ad Science in a research note on Tuesday, April 16th. Finally, Oppenheimer lowered their target price on shares of Integral Ad Science from $25.00 to $20.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 28th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $17.58.

Get Our Latest Report on IAS

Insider Transactions at Integral Ad Science

In related news, CFO Tania Secor sold 6,570 shares of Integral Ad Science stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $9.71, for a total value of $63,794.70. Following the sale, the chief financial officer now owns 230,888 shares in the company, valued at $2,241,922.48. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Integral Ad Science news, CFO Tania Secor sold 6,570 shares of the firm’s stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $9.71, for a total transaction of $63,794.70. Following the completion of the transaction, the chief financial officer now owns 230,888 shares of the company’s stock, valued at $2,241,922.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $10.24, for a total value of $32,532.48. Following the transaction, the chief accounting officer now directly owns 120,195 shares of the company’s stock, valued at approximately $1,230,796.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 80,195 shares of company stock worth $876,562. Insiders own 2.00% of the company’s stock.

About Integral Ad Science

(Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Featured Articles

Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IASFree Report).

Institutional Ownership by Quarter for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.